| |
| |
|
| Insider
Information: |
Krishnan Suma |
| Relationship: |
President, R&D, Direct... |
| City: |
Blacksburg |
| State: |
VA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
2 |
|
| Direct
Shares |
1,607,539 |
|
|
Indirect Shares
|
1,808,919 |
|
|
| Direct
Value |
$246,252,342 |
|
|
|
Indirect Value
|
$278,218,396 |
|
|
| Total
Shares |
3,416,458 |
|
|
| Total
Value |
$524,470,738 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -8.2%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Precigen Inc |
PGEN |
SVP--Product Development |
2016-01-29 |
56,657 |
2016-01-28 |
56,657 |
Premium* |
|
|
Krystal Biotech Inc |
KRYS |
President, R&D, Direct... |
2024-03-11 |
1,550,882 |
2024-03-11 |
1,752,262 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KRYS |
Krystal Biotech Inc |
President, R&D |
• • • |
2024-03-11 |
4 |
AS |
$167.99 |
$4,273,679 |
I/I |
(25,000) |
1,612,262 |
0 |
% |
|
| KRYS |
Krystal Biotech Inc |
President, R&D |
• • • |
2024-03-11 |
4 |
AS |
$168.15 |
$4,274,040 |
D/D |
(25,000) |
1,550,882 |
0 |
% |
|
| KRYS |
Krystal Biotech Inc |
President, R&D |
• • • |
2024-02-28 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,500 |
1,579,353 |
0 |
- |
|
| KRYS |
Krystal Biotech Inc |
President, R&D |
• • • |
2024-02-28 |
4 |
D |
$163.08 |
$566,051 |
D/D |
(3,471) |
1,575,882 |
0 |
- |
|
| KRYS |
Krystal Biotech Inc |
President, R&D |
• • • |
2024-02-28 |
4 |
OE |
$0.00 |
$0 |
I/I |
12,500 |
1,643,047 |
0 |
- |
|
| KRYS |
Krystal Biotech Inc |
President, R&D |
• • • |
2024-02-28 |
4 |
D |
$163.08 |
$943,418 |
I/I |
(5,785) |
1,637,262 |
0 |
- |
|
| KRYS |
Krystal Biotech Inc |
President, R&D |
• • • |
2024-02-26 |
4 |
D |
$157.00 |
$369,421 |
D/D |
(2,353) |
1,571,853 |
0 |
- |
|
| KRYS |
Krystal Biotech Inc |
President, R&D |
• • • |
2023-12-11 |
4 |
AS |
$104.26 |
$2,641,663 |
D/D |
(25,000) |
1,574,206 |
0 |
% |
|
| KRYS |
Krystal Biotech Inc |
President, R&D |
• • • |
2023-12-11 |
4 |
AS |
$104.41 |
$2,641,628 |
I/I |
(25,000) |
1,634,338 |
0 |
% |
|
| KRYS |
Krystal Biotech Inc |
President, R&D |
• • • |
2023-09-11 |
4 |
AS |
$125.23 |
$3,180,839 |
I/I |
(25,000) |
1,659,338 |
0 |
% |
|
| KRYS |
Krystal Biotech Inc |
President, R&D |
• • • |
2023-09-11 |
4 |
AS |
$125.23 |
$3,180,841 |
D/D |
(25,000) |
1,599,206 |
0 |
% |
|
| KRYS |
Krystal Biotech Inc |
President, R&D |
• • • |
2023-05-31 |
4 |
S |
$116.00 |
$2,905,977 |
I/I |
(25,000) |
1,684,338 |
0 |
% |
|
| KRYS |
Krystal Biotech Inc |
President, R&D |
• • • |
2023-05-31 |
4 |
S |
$115.98 |
$2,903,912 |
D/D |
(25,000) |
1,624,206 |
0 |
% |
|
| KRYS |
Krystal Biotech Inc |
President, R&D |
• • • |
2023-04-17 |
4 |
AS |
$85.55 |
$2,191,211 |
I/I |
(25,000) |
1,713,688 |
0 |
% |
|
| KRYS |
Krystal Biotech Inc |
President, R&D |
• • • |
2023-04-17 |
4 |
AS |
$85.55 |
$2,191,213 |
D/D |
(25,000) |
1,649,206 |
0 |
% |
|
| KRYS |
Krystal Biotech Inc |
President, R&D |
• • • |
2023-02-26 |
4 |
D |
$78.46 |
$239,852 |
D/D |
(3,057) |
1,674,206 |
0 |
- |
|
| KRYS |
Krystal Biotech Inc |
President, R&D |
• • • |
2023-01-18 |
4 |
AS |
$80.75 |
$230,955 |
D/D |
(2,852) |
1,677,263 |
0 |
% |
|
| KRYS |
Krystal Biotech Inc |
President, R&D |
• • • |
2023-01-18 |
4 |
AS |
$80.75 |
$230,874 |
I/I |
(2,851) |
1,738,688 |
0 |
% |
|
| KRYS |
Krystal Biotech Inc |
President, R&D |
• • • |
2023-01-17 |
4 |
AS |
$80.70 |
$1,788,998 |
I/I |
(22,149) |
1,741,539 |
0 |
% |
|
| KRYS |
Krystal Biotech Inc |
President, R&D |
• • • |
2023-01-17 |
4 |
AS |
$80.70 |
$1,788,916 |
D/D |
(22,148) |
1,680,115 |
0 |
% |
|
| KRYS |
Krystal Biotech Inc |
President, R&D |
• • • |
2023-01-04 |
4 |
AS |
$80.08 |
$300,140 |
I/I |
(3,748) |
1,763,688 |
0 |
% |
|
| KRYS |
Krystal Biotech Inc |
President, R&D |
• • • |
2023-01-04 |
4 |
AS |
$80.09 |
$315,385 |
D/D |
(3,938) |
1,702,263 |
0 |
% |
|
| KRYS |
Krystal Biotech Inc |
President, R&D |
• • • |
2023-01-03 |
4 |
AS |
$80.33 |
$136,554 |
D/D |
(1,700) |
1,706,201 |
0 |
% |
|
| KRYS |
Krystal Biotech Inc |
President, R&D |
• • • |
2023-01-03 |
4 |
AS |
$80.33 |
$136,567 |
I/I |
(1,700) |
1,767,436 |
0 |
% |
|
| KRYS |
Krystal Biotech Inc |
President, R&D |
• • • |
2022-12-29 |
4 |
AS |
$80.28 |
$643,511 |
I/I |
(8,010) |
1,769,136 |
0 |
% |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
